Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
3(60%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_1
1
20%
Ph not_applicable
1
20%
Ph early_phase_1
1
20%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 1Safety & dosage
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Completed(2)

Detailed Status

Recruiting2
Completed2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
3
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (33.3%)
Phase 11 (33.3%)
N/A1 (33.3%)

Trials by Status

recruiting240%
active_not_recruiting120%
completed240%

Recent Activity

3 active trials
Showing 5 of 5
active_not_recruitingnot_applicable

CB1R in Synthetic Psychoactive Cannabinoids

NCT03539575
recruitingphase_1

OMAR Opioid Use Disorder

NCT05683184
recruiting

Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

NCT01730781
completed

The Neural Correlates of Cannabis Use

NCT03104257
completedearly_phase_1

Brain Imaging of Cannabinoid Receptors

NCT03204305

Clinical Trials (5)

Showing 5 of 5 trials
NCT03539575Not Applicable

CB1R in Synthetic Psychoactive Cannabinoids

Active Not Recruiting
NCT05683184Phase 1

OMAR Opioid Use Disorder

Recruiting
NCT01730781

Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Recruiting
NCT03104257

The Neural Correlates of Cannabis Use

Completed
NCT03204305Early Phase 1

Brain Imaging of Cannabinoid Receptors

Completed

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5